In the past several years, cannabidiol (CBD) products have become more widely accepted for managing the side effects of breast cancer treatments. Even though CBD has become more popular, it is still new to many healthcare providers and their patients.
This webinar helps strengthen healthcare providers’ knowledge about CBD and how it can be used to manage patients’ treatment side effects.
Our speakers, Alex Capano DNP, CRNP, FNP-BC, from Ecofibre Limited and Brooke Worster, MD, FACP, from Thomas Jefferson University, cover topics including: CBD products and how they work; how CBD can be used to treat side effects of breast cancer treatment, including current research and anticipated future trends; and potential interactions between CBD and treatment. They also cover how to effectively respond to patients’ questions and guide them on CBD use.
We were unable to offer CEs for this program. However, certificates of participation were provided upon request through the evaluation process.
About our speakers
Alex Capano, DNP, CRNP, FNP-BC
Alex Capano, DNP, CRNP, FNP-BC, is the chief science officer at Ecofibre Limited, a global biotech company focused on hemp-derived supplements, food, textiles, and medical devices. Most recently, Dr. Capano published a study on the possibility of using cannabinoids to reduce opioid use in chronic pain patients. Current projects include researching CBD's role in treating chemotherapy-induced neuropathic pain and agitation in dementia patients, as well as identifying industrial applications of hemp-derived cannabinoids. She is also a senior fellow at Thomas Jefferson University and a board certified family nurse practitioner.
Brooke Worster MD, FACP
Brooke Worster MD, FACP, is an associate professor of medicine in the Thomas Jefferson University and Sidney Kimmel Medical College and practices supportive medicine and cancer pain management as the medical director of the Neu Center for Supportive Medicine and Cancer Survivorship. She is active teaching faculty for the medical students, residents and fellows and serves as director for the master’s program in cannabis at the Institute of Emerging Health Professions at SKMC. Her research interests, for which she has earned grant support involve the use, impact, and perceptions of cannabis in pain management and other serious illnesses.